Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BUDESONIDE DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for BUDESONIDE DELAYED-RELEASE CAPSULES. BUDESONIDE delayed-release capsules, for oral use Initial U.S. Approval:1997
Medication labelWhy this: Advisory · dailymed-prescription
Budesonide delayed-release capsules are indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon in patients 8 years of age and older. Budesonide delayed-release capsules are indicated for the maintenance of clinical remission of mild to moderate Crohn's disease involving the ileum and/or the ascending colon for up to 3 months in adults.
- generic_name
- budesonide
- product_names
- budesonide
- ndc
- 70518-4613, 16714-829, 70518-4613-1, 70518-4613-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en